ライフサイエンスコーパス: injection

1 to have RRD within 3 months of intravitreal injection.

2 exercise programme supplemented by a steroid injection.

3 ously inaccessible to therapies delivered by injection.

4 6, and 24 h and SPECT/CT at 6 h after tracer injection.

5 n all participants who received at least one injection.

6 h after injection, peaking by 24-48 h after injection.

7 added by automatic flow from distilled water injection.

8 ent fainted while receiving a glucocorticoid injection.

9 0 PYO among those reporting main drug use by injection.

10 weeks have elapsed since the last anti-VEGF injection.

11 early structured physiotherapy plus steroid injection.

12 diate or delayed side effects observed after injection.

13 ATE were taken at 0.5, 4, 24, and 96 h after injection.

14 ventional clinical images acquired 1 h after injection.

15 safety profiles than IP6 after subcutaneous injection.

16 sly forms a subcutaneous gel-depot following injection.

17 night food intake following intra-NTS leptin injection.

18 ccumulation is low until at least 5 min post injection.

19 undilated pupil followed by the intravitreal injection.

20 the water solubility of anticancer drugs for injection.

21 s 40 mg per 0.4 mL citrate free subcutaneous injection.

22 were probably or definitely attributable to injection.

23 ction and frequency interval of intravitreal injection.

24 , compatibility, and novel nanomedicines for injection.

25 resents a lower barrier than gold for charge injection.

26 GF monoclonal antibody (bevacizumab) upon IA injection.

27 ecific CD8+ T cells within 7 days after oHSV injection.

28 Safety was assessed up to 48 h post-injection.

29 eactions or complications after intravitreal injection.

30 ng mice were dynamically scanned 0-1 h after injection.

31 r the last intra-arterial chemotherapy (IAC) injection.

32 dy imaging was performed at 2 and 24 h after injection.

33 o more than 25 mug of protein for triplicate injection.

34 s or monthly intravitreal ranibizumab 0.5-mg injections.

35 robust ULM imaging of high-concentration MB injections.

36 earning following chronic hippocampal Abetao injections.

37 re and seen most commonly after intravitreal injections.

38 tients received chronic and serial anti-VEGF injections.

39 rmed Wnt activation following local beta-NGF injections.

40 MNsST was about 4:1 averaged across the four injections.

41 e recently, glabellar botulinum toxin, BoNT, injections.

42 tion for patients who require regular needle injections.

43 herence tomography (OCT)-guided intravitreal injections.

44 of treatment with retrobulbar triamcinolone injections.

45 ay be observed in patients who received IACS injections.

46 ty compared with control mice given cerulein injections.

47 The booster injection 1 year later had no additional effect.

48 gnificantly lower for 2 (16.4 vs 29.4), or 3 injections (1.4 vs 17.6) (both p < 0.001), with no diffe

49 on ($78 323.19-$292 449.87) and frequency of injections ($148 422.91-$388 096.81).

50 yopic CNV younger than 40 years needed fewer injections (2.00 +/- 0.76) than patients older than 40 y

51 e 1, vaccination comprised two intramuscular injections, 21 days apart.

52 re randomized 1:1 to receive 2 intramuscular injections 28 days apart (20 ug, n = 201) or placebo (n

53 r injection intervals or required no further injections, 3 maintained similar intervals, and 3 decrea

54 ws: 5% meth injection (5%), meth use without injection (33%), other substance use excluding meth (36%

55 ance use categories were as follows: 5% meth injection (5%), meth use without injection (33%), other

56 ), with no differences in eyes receiving >=4 injections (5.9 vs 5.1 respectively, p = 0.80).

57 % vs. 13.2%; P = 0.014), and fewer anti-VEGF injections (7.6 vs. 10.2; P = 0.001).

58 agent according to the patient age at first injection ($78 323.19-$292 449.87) and frequency of inje

59 xpand the repertoire of anticancer drugs for injection, acyl and oligo(lactic acid) ester prodrugs ha

60 .62-4.41]; P < .001), daily or more frequent injection (aHR, 1.45 [95% CI, 1.01-2.08]; P = .042), and

61 s of VA gain included number of intravitreal injections (AMD and PCV adjusted odds ratio, 12.1 [P = 0

62 roanalytical method was developed using flow injection analysis (FIA) with amperometric detection and

63 cal sensors, and their integration into flow-injection analyzers, microfluidic devices, and lab-on-a-

64 capillary into the HF lumen for automated CE injection and analysis.

65 arge carrier lifetimes as well as the charge injection and charge recombination dynamics depend large

66 achieved due to the low efficiency of charge injection and electron-hole recombination.

67 on the basis of patient age at time of first injection and frequency interval of intravitreal injecti

68 Key features were conjunctival ciliary injection and mutton fat keratic precipitation in all ey

69 tive in reducing risk of HIV and sequelae of injection and other drug use, and they have a continuing

70 ght eye (RE) excessive tearing, conjunctival injection and pain.

71 within the kidney, indicative of successful injection and that the cells remained viable for 3 days.

72 docurrent-clamp mode (for concurrent current injection and voltage recording) or into pseudovoltage-c

73 atured sustained activity with large current injections and a large, fast after-hyperpolarization, si

74 eated scruff restraint, intraperitoneal (IP) injections and anaesthesia negated the reduction in anxi

75 tations, including the need for subcutaneous injections and frequent monitoring.

76 ast blood clearance (0.63 %ID/g at 1 h after injection), and the highest activity uptake was in the s

77 symptoms, 60% had rash, 56% had conjunctival injection, and 27% had mucosal changes.

78 After intrahippocampal injection, and by contrast to the LRR-directed mAbs, the

79 non-toxic, marks blood flow for hours after injection, and effectively delineates tumors for improve

80 Female gender, drug injection, and methadone doses <60 mg were independently

81 At 2 weeks after injection, animals were euthanized and particle distribu

82 Among PWID, daily injection (aPR, 0.51 [95% CI, .31-.82]) was the primary

83 Repeated bolus injections are associated with higher costs and poor com

84 s over 1 year, with 4 or fewer or 10 or more injections associated with loss of vision or a plateau,

85 tion mass spectrometry (ESI-MS)-based sample injection at a sampling rate faster than current ESI and

86 mice treated with isoform 1 via intrajugular injection at age 28-30 days exhibited significant behavi

87 ministered to pregnant rats by intraamniotic injection at Embryonic Day 20, and pups were delivered b

88 Upon injection at the one-cell stage, FRET nanoprobes can be

89 tween mean letters gained and mean number of injections, between 4 and 10 injections over 1 year, wit

90 ia reperfusion injury mouse model after i.v. injection confirms the ability of injected neutrophils t

91 Following the injection, despite the lack of a redox counter-reaction

92 l acuity, spectral-domain (SD) OCT findings, injection details, and the development of neovascular se

93 tegrated into a custom-designed stopped-flow injection device to collect visible absorption and fluor

94 t the time delay between injury and polyplex injection directly impacts the magnitude of transfection

95 two study groups regarding age at first IAC injection, disease grouping at diagnosis, previously adm

96 ty and potency of LPS in the model using two injections distal to the cervix.

97 ction, among adults aged 20-59 years with an injection drug use (IDU) history.

98 -2016, for their ability to produce unbiased injection drug use (IDU) prevalence estimates.

99 unprecedented opioid crisis with increasing injection drug use (IDU)-related human immunodeficiency

100 e is an ongoing crisis and a risk factor for injection drug use (IDU).

101 rimental study included patients with active injection drug use and definite IE from January 2013 to

102 Independent predictors of infection were injection drug use as a risk factor for HIV acquisition

103 In many settings, recent or prior injection drug use remains a barrier to accessing direct

104 Poverty, injection drug use, and hepatitis C virus infection were

105 ction with human immunodeficiency virus, and injection drug use.

106 anding HCV treatment to all, irrespective of injection drug use.

107 ously administered treatments, number of IAC injections, drug dose, mean injection time, injection me

108 Peri-injection effects of FA were evaluated by 2-tailed paire

109 ing extraction and simultaneously guides the injection end of a separation capillary into the HF lume

110 l risk, and 5 drug-related outcomes (sharing injection equipment, injection frequency, opioid use, ge

111 ible and quantitative microsampling with low injection flow rates (as low as 15 pL/s).

112 Daily injections for basal insulin therapy are far from ideal

113 treatment burden associated with regular IVT injections for patients with nAMD.

114 azakizumab or placebo (4-weekly subcutaneous injections) for 12 weeks (part A), followed by a 40-week

115 0 mg loading dose administered as two 120 mg injections) for 3 months.

116 ion elevation of intraocular pressure (IOP), injection frequency, and number of injections were also

117 lated outcomes (sharing injection equipment, injection frequency, opioid use, general drug use, and p

118 to explain behavior related to electron/hole injection from the tip, interaction with UV light, and t

119 real anti-vascular endothelial growth factor injections from July 1, 2013, to September 1, 2019.

120 economy, the market share of gasoline direct injection (GDI) vehicles has increased significantly ove

121 bodies and availability, with a long-acting injection given every 8 weeks.

122 d between baseline factors and the number of injections given.

123 T7K24R mice given cerulein injections had increased pancreatic activation of trypsi

124 Duration of SNHL (60 versus 90 days post DT injection) had no effect on RAM performance.

125 edistribution is allowed, even though charge injection happens at a position far from the antigen bin

126 Antibody injection improved glucose tolerance in D734A INSR-expre

127 A single subpial AAV9 injection in adult pigs or non-human primates using a ne

128 The analysis based on CSF tracer injection in combination with immunohistochemistry showe

129 After intraportal injection in patients, amyloid deposits <15 um diameter

130 After intravitreous injection in rabbits, sunitinib microparticles self-aggr

131 RGCs and in vivo following intravitreal ET-1 injection in rats.

132 red with a control VNAR-hFc at 18 hours post-injection in wt mice.

133 NA injections in HD mouse striatum reduce mutant HTT protei

134 Patients received a mean of 27.56 injections in the superotemporal quadrant before RRD.

135 ven with a much lower dose and less frequent injections, in non-obese diabetic mice with insulin resi

136 between injections, increasing the number of injections increased survival time.

137 Depending upon the time-interval between injections, increasing the number of injections increase

138 and 207.6 %ID/g, respectively, at 1 h after injection), indicating a renal excretion pathway.

139 propose a multi-process causal mechanism for injection-induced earthquakes through a case study of th

140 f 17 patients (64.7%) either increased their injection intervals or required no further injections, 3

141 t (111)In-diethylenetriaminepentaacetic acid injection into the CSF intraventricular space followed b

142 ns of retrograde labeling result from tracer injections into different NTS subdivisions, with dual re

143 pressed the mRNA over 72 h after intradermal injections into primary, human, skin explants.

144 ophysiological assessments in vivo after mAb injections into the rodent hippocampus.

145 g IOP elevation associated with intravitreal injections is unknown.

146 minor delays between symptom onset and first injection led to less optimistic vision gains and were a

147 We demonstrate a compact, self-injection locked, Fabry-Perot semiconductor laser diode

148 th ICG dose >=1 mg, albumin dissolvent, post-injection lung ventilation, radiologically solid nodules

149 The cumulative number of intravitreal injections may be an independent risk factor for recurre

150 Following acute injection, MCAM and naltrexone decreased fentanyl self-a

151 ion funnel traps, and other conventional ion injection mechanisms produce ion pulse widths typically

152 as type of anesthesia, preparation, or post-injection medication, increased the risk of a complicati

153 injections, drug dose, mean injection time, injection method (pulsatile vs. continuous), or concomit

154 riasiform dermatitis in an IL-23 intradermal injection model.

155 (16.5 g L(-1)) expected during Fe(0) in situ injection mostly yielded TCE abiotic reduction to ethene

156 were no significant differences between the injection (n = 38) and sponge (n = 40) groups in surgica

157 sporozoites via mosquito bite (n = 336), or injection (n = 51).

158 se duration, disease-free duration, previous injection number, microaneurysms in the superficial vasc

159 rwent whole-body PET/CT imaging 90 min after injection of (18)F-SKI (mean, 241.24 +/- 116.36 MBq) as

160 Results: No adverse events occurred after injection of (18)F-SKI.

161 lerance before and 40-min after double-blind injection of .08 mg/kg morphine or placebo.

162 An intravenous injection of 1.5 ml/kg of body mass of non-ionic contras

163 ft model of acute myeloid leukemia, a single injection of 10 million Jurkat cells delivered DiD to ~1

164 tivation and CGRP release, goats received an injection of 2,4,6-trinitro-benzenesulfonic-acid (TNBS)

165 anipulating 20E signaling through the direct injection of 20E or the application of a 20E agonist can

166 A delay from symptom onset to first injection of 30 days or more predicted higher incidence

167 osis after BDL had increased hepatic PFKFB3; injection of 3PO immediately after the surgery prevented

168 Injection of 500 mug resulted in excellent discriminatio

169 These findings demonstrate that a single injection of a long-acting prodrug of the PARP inhibitor

170 columns packed with 40-50 mesh Ottawa sand, injection of a PAC (1000 mg/L) + polyDADMAC (5000 mg/L)

171 we show preliminary evidence that peripheral injection of alpha-syn fibrils induces unique patterns o

172 Our results suggest that peripheral injection of alpha-syn has acute systemic effects on the

173 Intrathymic injection of an AAV8-ZAP-70 vector into ZAP-70(-/-) mice

174 In vivo, intraperitoneal injection of an antimiR to miR-370-3p into heart failure

175 y involves HSPC mobilization and intravenous injection of an integrating HDAd5/35++ vector.

176 e encephalomyelitis (EAE), we show here that injection of anti-hnRNP A1 antibodies, in contrast to co

177 Intraperitoneal injection of anti-SQSTM1-neutralizing monoclonal antibod

178 Anaphylaxis was induced by intravenous injection of antigen or anti-huIgE mAb.

179 or complement attack and was observed after injection of both syngeneic and xenogeneic cells.

180 Intravascular injection of certain adeno-associated virus vector serot

181 Injection of cerulein for 2 days induced progressive pan

182 This is followed by a further injection of DNA as a competitor, either in a plasmid or

183 ese exosomes was demonstrated by stereotaxic injection of exosomes isolated from alpha-synuclein pref

184 Our findings suggest that a single local injection of fluvastatin following tooth extraction can

185 toxicity studies revealed that intravitreal injection of griseofulvin in adult mice does not disrupt

186 Intratumoral injection of HD/Se/ICG gel with NIR laser irradiation pr

187 sent in plasma from mice acutely inflamed by injection of high dose of lipopolysaccharide (LPS).

188 f redox-neutral reactions by electrochemical injection of holes and electrons, also known as "electro

189 Repeated injection of HoxB8 progenitors also allowed us to mainta

190 After a single intravenous injection of human CD34+ cells, NSG-SGM3 mice supported

191 Dynamic (13)C MRSI was performed following injection of hyperpolarized [1-(13)C]pyruvate.

192 yperW NMR spectra acquired upon simultaneous injection of hyperpolarized water and hypoxanthine.

193 Injection of inhibitory antibodies to the alpha subunit

194 ith caerulein stimulation or intraperitoneal injection of l-arginine in mice with deletion of interle

195 rauterine inflammation in mice with a single injection of lipopolysaccharide (LPS).

196 symptomatic mouse model of DMD carriers via injection of mdx (murine DMD) embryonic stem cells (ESCs

197 Injection of non-safe microcapsule dose leads to carrier

198 l decrease in contaminant concentration upon injection of nZVI suspensions in the contaminated zones.

199 echnique of using sub-perfluorocarbon liquid injection of OVD secured single-layered flaps intraopera

200 Injection of pharmacotherapy into the suprachoroidal spa

201 Intraperitoneal injection of pLL induced IL-1beta, suggesting that conta

202 Subconjunctival (SCT) injection of Sunb-malate MS provided a prolonged ocular

203 Finally, injection of synthetic hepcidin at the site of infection

204 On day 0, participants received a first injection of tetravalent vaccine (Ad26.Mos4.HIV or place

205 A single low-dose injection of the hybrid system locally reduces inflammat

206 Upon direct peritumoral injection of the hydrogel and with the treatment of 808

207 S hydrogels form spontaneously after syringe injection of the PEDOT:PSS suspension into the desired l

208 n, here we investigated whether intracranial injection of this strain can induce optic neuritis by re

209 Moreover, intracerebroventricular injection of two antisense oligonucleotides in wild-type

210 ed MSDB-specific knockout of CB1 or MAGL via injection of virally-delivered Cre recombinase into the

211 ) is the source of the largest stratospheric injection of volcanic gases in the Common Era.

212 277 participants were randomized to receive injections of 1.25 mg bevacizumab (n = 139) or 0.5 mg ra

213 rs (NMDARs) during development [subcutaneous injections of 30 mg/kg ketamine (KET) on postnatal days

214 Injections of 300 mg/kg of GBP significantly increased t

215 E) mice developed liver tumors in 3-5 weeks; injections of anti-PD1 did not slow tumor development.

216 Intraperitoneal injections of CD4-CCR5-VLP produced only subneutralizing

217 Mice were given hydrodynamic tail vein injections of clustered regularly interspaced short pali

218 s using male rats demonstrate that intra-NTS injections of DCPP-ene attenuate reduction of overnight

219 Unilateral injections of dextran-biotin (anterograde tracer; 20% in

220 cipants were randomized to receive 6 monthly injections of either 1.25 mg bevacizumab (n = 86) or 0.5

221 a 2:1 ratio to receive monthly subcutaneous injections of evolocumab (420 mg) or placebo.

222 ed with maribarir, intravitreal and systemic injections of foscarnet, and anti-Cytomegalovirus human

223 find little evidence to support significant injections of halogens into the stratosphere.

224 ned acute seizures evoked by intraperitoneal injections of kainic acid (KA) and pilocarpine in mice w

225 ficient (W/W(V)) mice, and W/W(V) mice given injections of mast cells derived from wild-type or Ptgs2

226 Bolus intravenous injections of microbubbles are standard practice, but dy

227 ar fat pads of NSG mice, and mice were given injections of penfluridol daily for 28 days.

228 ignaling that can be reversed by post-injury injections of Plerixafor (AMD3100), a small molecule inh

229 ciated with up-regulation of sialidases, and injections of sialidase inhibitors attenuate bleomycin-i

230 cause global climatic perturbations through injections of soot into the upper atmosphere.

231 was to characterize the effects of systemic injections of the CB1r agonist (CP55940) on the balanced

232 itor DAPT, intestine tissues from mice given injections of the gamma-secretase inhibitor dibenzazepin

233 Injections of TRH into the RVLM and dorsomedial hypothal

234 tation were more likely to have conjunctival injection on initial examination (delayed, 73% vs. early

235 hypermethylation was not observed after THC injection or in the subsequent generation.

236 roduce the characteristic foam through CO(2) injection or salts addition.

237 mean number of injections, between 4 and 10 injections over 1 year, with 4 or fewer or 10 or more in

238 ple normal lymph nodes as early as 2 h after injection, peaking by 24-48 h after injection.

239 high analytical frequency, approximately 96 injections per hour, together with adequate detection li

240 Intrabursal injections performed with KURAMOCHI and COV362 cells did

241 icipants were randomized 2:1 to FAi or sham (injection plus standard of care) treatment.

242 The number of prior injections positively correlated with the number of SLG.

243 in, we describe a straightforward single hot injection procedure revolving around In(I)Cl as the key

244 mpared with other intraocular and periocular injection procedures.

245 ds to peaks in the electropherogram from the injection process that are useful for precisely defining

246 Importantly, no injection protocol parameter, such as type of anesthesia

247 Injection rate did not influence the rate of change in D

248 Anti-VEGF injection rates and treatment switches were not importan

249 and stratified based on number of anti-VEGF injections received over 1 year.

250 Mean number of injections received was similar for eyes with versus wit

251 Five participants did not complete the two-injection regimen with mosquito feeding at day 42, but w

252 omena occurring at steady and pulsating flow injection regimes were analyzed using steady and unstead

253 transport associated with this hot-electron injection remains unclear.

254 2.1 [P = 0.001] and 12.5 [P = 0.004] for >=7 injections, respectively) and baseline VA of 20 logMAR l

255 Conversely, CTB injections restricted to TeO retrogradely labeled neuron

256 emia and thrombocytopenia following systemic injection, side effects that might be eliminated by a gu

257 AAV8-VEGF-C injection significantly increased meningeal lymphangioge

258 GBS67-CpGODN+L formed a vaccine depot at the injection site and induced a remarkable increase of func

259 e ixekizumab groups were nasopharyngitis and injection site reaction.

260 gen, while precipitating the allergen at the injection site to reduce the risk of anaphylaxis.

261 by short-term, mild-to-moderate pain at the injection site, fatigue, and headache.

262 (of both delivery system and antigen) at the injection site, the cationic emulsions did not.

263 nal cord response, not observed at the nerve injection site.

264 ly immunocompromised NSG mice by varying the injection site.

265 Injection-site reactions were common.

266 lits bacterial samples upon a simple syringe injection step to initiate AST against all antibiotics.

267 in mice kidneys and liver at 30 minutes post-injection than does a commercially used Gd(III) agent an

268 Six months after injection, the anterior olfactory nucleus and piriform c

269 ive three initial monthly ranibizumab 0.5 mg injections, then retreatment guided by either best-corre

270 The success rates of stem cell injection therapies seem to be comparable with those of

271 s, number of IAC injections, drug dose, mean injection time, injection method (pulsatile vs. continuo

272 Following injection to AD transgenic mice, TDP-43 induced inflamma

273 e samples were collected for up to 4 h after injection to assess metabolite-corrected radioactivity i

274 Average duration from time of injection to diagnosis of RRD was 27 days (range, 5-43 d

275 quired imaging prior to and post ferumoxytol injection to discriminate exogenous iron susceptibility

276 d tomography (CT) angiogram rely on contrast injection to enhance the radio-density within the vessel

277 Ovariectomized females were given daily injections to approximate hormone levels during gestatio

278 female with history of pitcher plant extract injections to her face for chronic migraine, who later d

279 -wide off-target analysis by two-cell embryo injection) to detect off-target mutations by editing one

280 d HER2-negative tumors as early as 2 h after injection (tumor-to-contralateral breast ratio, 37 +/- 1

281 solution, mobile phase flow rate and sample injection volume were individually studied and optimized

282 e are then calibrated to their equivalent QC injection volumes for comparative analysis.

283 The intravitreal injection was given by a single surgeon.

284 The percentage of eyes receiving 1 injection was significantly higher in naive vs PT DME ey

285 At 40 min after the injection, well after the intraocular pressure normalize

286 hanges occur in the brain by four weeks post-injection, well before alpha-syn pathology reaches the b

287 risk factors for RRD other than intravitreal injection were present in 5 of 13 eyes (38%), including

288 re (IOP), injection frequency, and number of injections were also evaluated.

289 Self-reports of anti-VEGF injections were collected.

290 Leukemia inhibitory factor (LIF) injections were given intraperitoneally and implantation

291 Monthly injections were more effective than as-needed approach,

292 Baseline CST and number of injections were not predictive (P >= 0.101).

293 vaccine (Ad26.Mos.HIV or placebo), and those injections were repeated 12 weeks later.

294 PET scans (20-40 min after injection) were evaluated visually for complete or incom

295 ically diagnosed within 35 days after an IAC injection, were noted.

296 nts to bone healing following local beta-NGF injections which resulted in a decrease in cartilage and

297 enhanced humoral responses compared with IM injection with higher HAI geometric mean titres (GMTs) a

298 Importantly, the intratumoral injection with the oncolytic virus overcomes PD-L1-media

299 Patients were treated with intravitreal injections with bevacizumab; ranibizumab; or photodynami

300 ion rates were low, representing 1.9% of all injections, with 1031 unique complications in 685 patien